ARTICLE SUMMARY:
Medtech and pharma have long stood on opposite sides of a culture divide. Talk of drug-device convergence has, mostly, remained just that. But digital technology is now bridging the gap, creating new treatment modalities where data, not tools or drugs, are king.
There are lots of reasons why medical devices and pharmaceutical players have, until now, remained in separate camps.
